Core Viewpoint - Astera Labs Inc (NASDAQ:ALAB) shares are experiencing significant declines following the release of their latest earnings report and guidance, amidst broader concerns in the tech sector regarding profit sustainability related to AI investments [1][2]. Financial Performance - Astera Labs reported fourth-quarter revenue of $270.6 million, exceeding Wall Street's estimate of $249.5 million, and adjusted earnings of 58 cents per share, surpassing the expected 51 cents [2]. - The company projected first-quarter sales between $286 million and $297 million, which is above consensus estimates, yet this positive outlook has not prevented short-term selling pressure [2]. Market Reaction - The stock fell nearly 20% on Wednesday, attributed to profit-taking after a 40% increase over the past year, leading to elevated valuations compared to peers [3]. - Concerns regarding a leadership transition, with CFO Mike Tate stepping down and Desmond Lynch set to take over, may have contributed to investor apprehension despite the earnings beat [4]. Long-Term Outlook - Despite short-term pressures, Wall Street remains optimistic about Astera Labs, with JPMorgan maintaining an Overweight rating and adjusting the price target from $215 to $205, citing strong demand for AI infrastructure [5]. - Analysts anticipate that Astera's products, particularly the Scorpio and Taurus connectivity chips, will drive revenue growth through 2026, even as the company faces profitability challenges [6]. Technical Analysis - Astera Labs is currently trading 23.1% below its 20-day simple moving average (SMA) and 25.1% below its 100-day SMA, indicating a bearish trend in the short to medium term [7]. - The stock has increased 46.62% over the past year and is closer to its 52-week highs than lows, with a neutral RSI of 42.70 and a bearish MACD [7][8]. Business Model - Astera Labs specializes in semiconductor-based connectivity solutions for cloud and AI infrastructure, integrating semiconductor technology, microcontrollers, sensors, and software to enhance performance and scalability [10]. - The company's focus on AI-driven platforms and recent innovations are crucial for maintaining a competitive edge in a rapidly evolving market [11]. Market Position - According to the Benzinga Edge scorecard, Astera Labs shows strong momentum, outperforming the market, but is trading at a premium relative to peers, which may concern value-focused investors [12]. - As of Thursday, ALAB shares were down 11.94% at $126.59, with a value score of 3.86 and a momentum score of 70.97, indicating strong market performance [13].

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO [Accessibility Statement] Skip NavigationNEW YORK, Feb. 12, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. ("Inovio" or the "Company") (NASDAQ: INO) and certain officers. The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under 26-cv-00803, is on b ...

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM [Accessibility Statement] Skip NavigationNEW YORK, Feb. 12, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed on behalf of shareholders of Quantum Biopharma Ltd. ("Quantum" or the "Company") (NASDAQ: QNTM). Such investors are advised to contact Danielle Peyton at [[email protected]] or 646-581-9980, ...

Financial Data and Key Metrics Changes - Pre-tax income for Q4 2025 was $113 million, down from $134 million in Q4 2024, with full-year pre-tax income at $561 million compared to $584 million in 2024, reflecting a decline of 4% [3] - Net income for Q4 2025 was $81 million, or $8.65 per share, compared to $111 million, or $11.56 per share in Q4 2024; full-year net income was $419 million, or $44.44 per share, down from $462 million, or $48.22 per share in 2024 [3][4] Business Line Data and Key Metrics Changes - Petroleum Additives sales for Q4 2025 were $585 million, down from $626 million in Q4 2024; operating profit for this segment was $107 million, compared to $136 million in the same period last year [4][5] - For the full year, Petroleum Additives sales were $2.5 billion, down from $2.6 billion in 2024, with operating profit at $520 million compared to $592 million in 2024 [6] - Specialty Materials sales for Q4 2025 were $49 million, up from $27 million in Q4 2024, with operating profit increasing to $7 million from about $2 million [7][8] - Full-year Specialty Materials sales were $182 million, compared to $141 million in 2024, with operating profit rising to $47 million from $17 million [9] Market Data and Key Metrics Changes - Shipments in the Petroleum Additives segment declined by 6% in Q4 2025 and 4.9% for the full year, attributed to market softness and strategic decisions to manage profitability [5][6] Company Strategy and Development Direction - The company is focused on investing in technology, optimizing inventory levels, and improving portfolio profitability, with a commitment of approximately $1 billion towards expanding capacity in the Specialty Materials segment [9][10] - The company aims to promote long-term value for shareholders and customers, emphasizing a safety-first culture, customer-focused solutions, and technology-driven products [11] Management's Comments on Operating Environment and Future Outlook - Management noted challenges from ongoing inflation, tariffs, and market softness impacting shipments, but expressed confidence in the strength of the petroleum additives and specialty materials segments [6][10] - The company generated solid cash flows in 2025, allowing for shareholder returns through share repurchases and dividends, while also reducing total debt by $88 million [10] Other Important Information - The effective tax rate increased in 2025 compared to 2024, significantly impacting net income and EPS [4] - The company reported a net debt to EBITDA ratio of 1.1 times as of December 31, 2025, slightly down from 1.2 at the end of 2024 [10] Q&A Session Summary - No specific questions or answers were provided in the content, indicating that the conference call concluded without a Q&A segment [12]

(NYSE: ARDT). Such...][More Releases From This Source]## Explore[Banking & Financial Services][News Releases in Similar Topics]---- -- Pomerantz Law Firm Announces the Filing of a Class Action Against SLM Corporation and Certain Officers - SLM [Accessibility Statement] Skip NavigationNEW YORK, Feb. 12, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against SLM Corporation ("SLM" or the "Company") (NASDAQ: SLM) and certain officers. The class action, filed in the Unit ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2025 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from __________ to __________ Commission file number 001-31392 PLURI INC. (Exact name of registrant as specified in its charter) | Nevada | 98-0351734 | | --- | --- | | (State or other jurisdict ...

Exhibit 99.1 SEATTLE, WA. February 12, 2026 -- Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the fourth quarter and full year ended December 31, 2025. "Since 2021, we've delivered more than $500 million in discretionary profit, growing at a 22% CAGR, including over $150 million last year alone," said Margi Tooth, Chief Executive Officer and President of Trupanion. "In 2025, we achieved our 15% annual margin target, while incr ...

Exhibit 99.1 Corsair Reports Strong Revenue and Profit Growth for 4Q25 and FY25 12% Full Year 2025 Revenue Growth to $1,472.5 Million 30% Full Year 2025 GAAP Gross Profit Increase to $425.9 Million Record Full Year 2025 GAAP Gross Margin of 28.9% 84% Full Year increase in Adjusted EBITDA to $100.6 Million, Above Guidance $50 Million Share Repurchase Approved MILPITAS, CA, February 12, 2026 – Corsair Gaming, Inc. (Nasdaq: CRSR) ("Corsair" or the "Company"), a leading global provider and innovator of high-per ...

Expedia Group Reports Fourth Quarter and Full Year 2025 Results Exceeded fourth quarter guidance with double-digit gross bookings and revenue growth y/y Room nights up 9% y/y, driven by sustained strength internationally and in the U.S. Expanded Adjusted EBITDA margins y/y SEATTLE, WA – February 12, 2026 – Expedia Group, Inc. (NASDAQ: EXPE) announced financial results today for the fourth quarter and full year ended December 31, 2025. Key Highlights (All comparisons year-over-year) • Booked room nights grew ...

Q4 2025 Shareholder Letter © 2026 Rivian. All rights reserved. 2 2025 was a year of focused execution at Rivian as we laid the foundations for scaling our business. Our team progressed the development of our technology roadmap and R2, our mass-market midsized SUV, while simultaneously driving continued improvement in our customer experience and our path to profitability. While we continue to face near-term uncertainty from macroeconomic and policy developments, we remain focused on our long-term growth stra ...